Cancer Anorexia-Cachexia Syndrome Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cancer Anorexia-Cachexia Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
Segment by Application
Hospital
Clinic
Others
By Company
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
